{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:07Z","timestamp":1790630647563,"version":"4.1.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152471","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T18:14:29Z","timestamp":1459275269000},"page":"e0152471","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["An Anti-\u03b2-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome"],"prefix":"10.1371","volume":"11","author":[{"given":"Pavel V.","family":"Belichenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rime","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorianne","family":"Rey-Bellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pihlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Plassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Vuillermot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Giriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Nosheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Kleschevnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Valletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K. S.","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon R.","family":"Linke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Granet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorin","family":"Mlaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pilar","family":"Lopez-Deber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Pearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Muhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1101\/sqb.2003.68.425","article-title":"Chromosome 21 and Down syndrome: the post-sequence era","volume":"68","author":"SE Antonarakis","year":"2003","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"e10659","DOI":"10.1371\/journal.pone.0010659","article-title":"Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome","volume":"5","author":"JA Moncaster","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mrdd.20157","article-title":"Epidemiology of Down syndrome","volume":"13","author":"SL Sherman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"5\u20136","key":"ref4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00335-011-9321-y","article-title":"Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions","volume":"22","author":"X Sturgeon","year":"2011","journal-title":"Mamm Genome"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome","volume":"17","author":"KE Wisniewski","year":"1985","journal-title":"Ann Neurol"},{"issue":"Pt 10","key":"ref6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2788.2006.00842.x","article-title":"Dementia and mortality in persons with Down's syndrome","volume":"50","author":"A Coppus","year":"2006","journal-title":"J Intellect Disabil Res"},{"key":"ref7","article-title":"Down syndrome and Alzheimer's disease: Common pathways, common goals","author":"D Hartley","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome","volume":"46","author":"F Lai","year":"1989","journal-title":"Arch Neurol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mrdd.20163","article-title":"Alzheimer's disease in Down syndrome: Neurobiology and risk","volume":"13","author":"WB Zigman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.180.5.405","article-title":"Genetic and host factors for dementia in Down's syndrome","volume":"180","author":"N Schupf","year":"2002","journal-title":"Br J Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/apt.10.1.50","article-title":"Down's syndrome and dementia","volume":"10","author":"LR Stanton","year":"2004","journal-title":"Advances in Psychiatric Treatment"},{"issue":"Pt 11","key":"ref12","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/brain\/awl237","article-title":"Phenotype associated with APP duplication in five families","volume":"129","author":"L Cabrejo","year":"2006","journal-title":"Brain"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tig.2009.12.004","article-title":"The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects","volume":"26","author":"K Sleegers","year":"2010","journal-title":"Trends Genet"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1034\/j.1399-0004.2002.620506.x","article-title":"The changing survival profile of people with Down's syndrome: implications for genetic counselling","volume":"62","author":"EJ Glasson","year":"2002","journal-title":"Clin Genet"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"AH Bittles","year":"2007","journal-title":"Eur J Public Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1192\/bjp.162.5.711a","article-title":"Down's syndrome, longevity, and Alzheimer's disease","volume":"162","author":"VP Prasher","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/gps.1077","article-title":"Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population","volume":"19","author":"VP Prasher","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"412536","DOI":"10.1155\/2012\/412536","article-title":"Aging and down syndrome","volume":"2012","author":"E Head","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/157488710790820490","article-title":"The pulse of drug development for Alzheimer's disease","volume":"5","author":"MS Rafii","year":"2010","journal-title":"Rev Recent Clin Trials"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","article-title":"Immunology and immunotherapy of Alzheimer's disease","volume":"6","author":"HL Weiner","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"C Hock","year":"2003","journal-title":"Neuron"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"CR Jack Jr","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"CR Jack Jr","year":"2013","journal-title":"Lancet Neurol"},{"issue":"226","key":"ref24","doi-asserted-by":"crossref","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease","volume":"6","author":"AM Fagan","year":"2014","journal-title":"Sci Transl Med"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"RJ Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"DC Ryman","year":"2014","journal-title":"Neurology"},{"key":"ref27","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down syndrome","volume":"384","author":"MT Davisson","year":"1993","journal-title":"Prog Clin Biol Res"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neurobiolaging.2003.10.010","article-title":"Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen","volume":"25","author":"CL Hunter","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"DM Holtzman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.20337","article-title":"Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome","volume":"480","author":"PV Belichenko","year":"2004","journal-title":"J Comp Neurol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","article-title":"Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer","volume":"43","author":"M Faizi","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"27","key":"ref32","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1523\/JNEUROSCI.1673-12.2012","article-title":"Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists","volume":"32","author":"AM Kleschevnikov","year":"2012","journal-title":"J Neurosci"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"A Salehi","year":"2006","journal-title":"Neuron"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"A Salehi","year":"2009","journal-title":"Sci Transl Med"},{"issue":"23","key":"ref35","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.0703137104","article-title":"Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice","volume":"104","author":"A Muhs","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1073\/pnas.90.7.2955","article-title":"Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase","volume":"90","author":"C Bowes","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cne.21895","article-title":"Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome","volume":"512","author":"PV Belichenko","year":"2009","journal-title":"J Comp Neurol"},{"issue":"282","key":"ref38","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.M611050200","article-title":"Rodent Abeta modulates the solubility and distribution of amyloid deposits in transgenic mice","volume":"3","author":"JL Jankowsky","year":"2007","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-60761-744-0_3","article-title":"Isolation of low-n amyloid beta-protein oligomers from cultured cells, CSF, and brain","volume":"670","author":"GM Shankar","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e0118379","DOI":"10.1371\/journal.pone.0118379","article-title":"A gamma-secretase inhibitor, but not a gamma-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP","volume":"10","author":"AM Weissmiller","year":"2015","journal-title":"PLoS ONE"},{"issue":"17","key":"ref41","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1523\/JNEUROSCI.4322-12.2013","article-title":"Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling","volume":"33","author":"K Zhang","year":"2013","journal-title":"J Neurosci"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"LA Greene","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"ref43","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1016\/S0021-9258(18)42291-0","article-title":"The alpha 2-macroglobulin receptor\/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A","volume":"267","author":"MZ Kounnas","year":"1992","journal-title":"J Biol Chem"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"e0134861","DOI":"10.1371\/journal.pone.0134861","article-title":"Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues","volume":"10","author":"PV Belichenko","year":"2015","journal-title":"PLoS ONE"},{"issue":"18","key":"ref45","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome","volume":"29","author":"NP Belichenko","year":"2009","journal-title":"J Neurosci"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2214\/ajr.168.4.9124106","article-title":"Iron overload in reticuloendothelial systems of pediatric oncology patients who have undergone transfusions: MR observations","volume":"168","author":"PY Emy","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.161.9.5016","article-title":"Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration","volume":"161","author":"Y Akwa","year":"1998","journal-title":"J Immunol"},{"issue":"18","key":"ref48","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1073\/pnas.181219298","article-title":"Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion","volume":"98","author":"JD Cooper","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neurobiolaging.2006.04.007","article-title":"Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice","volume":"28","author":"TJ Seabrook","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref50","first-page":"103","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations","volume":"9","author":"KJ Gardiner","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"E Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"ref52","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1073\/pnas.191118298","article-title":"Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease","volume":"98","author":"A Monsonego","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","first-page":"204","article-title":"Immunology of Down syndrome: a review","volume":"7","author":"AG Ugazio","year":"1990","journal-title":"Am J Med Genet Suppl"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4933-8-4","article-title":"Inflammatory and Immunological parameters in adults with Down syndrome","volume":"8","author":"MB Trotta","year":"2011","journal-title":"Immun Ageing"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"S Gilman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"JM Orgogozo","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"I Ferrer","year":"2004","journal-title":"Brain Pathol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2012-02-413831","article-title":"TLR4 and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T-cell independent isotype switch in mice","volume":"121","author":"M Pihlgren","year":"2013","journal-title":"Blood"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0197-4580(02)00124-0","article-title":"A safer vaccine for Alzheimer's disease?","volume":"23","author":"EM Sigurdsson","year":"2002","journal-title":"Neurobiol Aging"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0324280","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:28:53Z","timestamp":1692257333000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152471"}},"subtitle":[],"editor":[{"given":"Yann","family":"Herault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152471","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}